Skip to main content

Advertisement

SpringerLink
Log in

Systematic analysis of the function and prognostic value of RNA binding protein in head and neck squamous cell carcinoma

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Objective

Dysregulation of RNA binding proteins (RBPs) plays an important role in controlling processes in cancer development. However, the function of RBPs has not been thoroughly and systematically documented in head and neck cancer. We aim to explore the role of RPB in the pathogenesis of HNSC.

Methods

We obtained HNSC gene expression data and corresponding clinical information from The Cancer Genome Atlas (TCGA) and the GEO databases, and identified aberrantly expressed RBPs between tumors and normal tissues. Meanwhile, we performed a series of bioinformatics to explore the function and prognostic value of these RBPs.

Results

A total of 249 abnormally expressed RBPs were identified, including 101 downregulated RBPs and 148 upregulated RBPs. Using least absolute shrinkage and selection operator (LASSO) and univariate Cox regression analysis, the 15 RPBs were identified as hub genes. With the 15 RPBS, the prognostic prediction model was constructed. Further analysis showed that the high-risk score of the patients expressed a better survival outcome. The prediction model was validated in another HNSC dataset, and similar findings were observed.

Conclusions

Our results provide novel insights into the pathogenesis of HNSC. The fifteen RBP gene signature exhibited the predictive value of moderate HNSC prognosis, and have potential application value in clinical decision-making and individualized treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

Availability of data and material

Data availability could be obtained from TCGA website.

References

  1. Preciado DA, Matas A, Adams GL (2002) Squamous cell carcinoma of the head and neck in solid organ transplant recipients. Head Neck 24:319–325

    Article  Google Scholar 

  2. Patel BP, Shah PM, Rawal UM, Desai AA, Shah SV, Rawal RM, Patel PS (2005) Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. J Surg Oncol 90:81–88

    Article  CAS  Google Scholar 

  3. Choi KK, Kim MJ, Yun PY, Lee JH, Moon HS, Lee TR, Myoung H (2006) Independent prognostic factors of 861 cases of oral squamous cell carcinoma in Korean adults. Oral Oncol 42:208–217

    Article  Google Scholar 

  4. Wozniak A, Szyfter K, Szyfter W, Florek E (2012) Head and neck cancer–history. Przegl Lek 69:1079–1083

    PubMed  Google Scholar 

  5. Mehanna H, Paleri V, West CM, Nutting C (2010) Head and neck cancer–part 1: epidemiology, presentation, and prevention. BMJ 341:c4684

    Article  CAS  Google Scholar 

  6. Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30

    Article  Google Scholar 

  7. Chi AC, Day TA, Neville BW (2015) Oral cavity and oropharyngeal squamous cell carcinoma—an update. CA Cancer J Clin 65:401–421

    Article  Google Scholar 

  8. Gerstberger S, Hafner M, Tuschl T (2014) A census of human RNA-binding proteins. Nat Rev Genet 15:829–845

    Article  CAS  Google Scholar 

  9. Velasco MX, Kosti A, Penalva LOF, Hernandez G (2019) The diverse roles of RNA-binding proteins in glioma development. Adv Exp Med Biol 1157:29–39

    Article  CAS  Google Scholar 

  10. Fredericks AM, Cygan KJ, Brown BA, Fairbrother WG (2015) RNA-binding proteins: splicing factors and disease. Biomolecules 5:893–909

    Article  CAS  Google Scholar 

  11. Suzuki A, Niimi Y, Shinmyozu K, Zhou Z, Kiso M, Saga Y (2016) Dead end1 is an essential partner of NANOS2 for selective binding of target RNAs in male germ cell development. EMBO Rep 17:37–46

    Article  CAS  Google Scholar 

  12. Chang ET, Parekh PR, Yang Q, Nguyen DM, Carrier F (2016) Heterogenous ribonucleoprotein A18 (hnRNP A18) promotes tumor growth by increasing protein translation of selected transcripts in cancer cells. Oncotarget 7:10578–10593

    Article  Google Scholar 

  13. Chenard CA, Richard S (2008) New implications for the QUAKING RNA binding protein in human disease. J Neurosci Res 86:233–242

    Article  CAS  Google Scholar 

  14. Neelamraju Y, Gonzalez-Perez A, Bhat-Nakshatri P, Nakshatri H, Janga SC (2018) Mutational landscape of RNA-binding proteins in human cancers. RNA Biol 15:115–129

    Article  Google Scholar 

  15. Wichmann G, Rosolowski M, Krohn K, Kreuz M, Boehm A, Reiche A, Scharrer U, Halama D, Bertolini J, Bauer U et al (2015) The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer. Int J Cancer 137:2846–2857

    Article  CAS  Google Scholar 

  16. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47

    Article  Google Scholar 

  17. Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16:284–287

    Article  CAS  Google Scholar 

  18. Wu TT, Chen YF, Hastie T, Sobel E, Lange K (2009) Genome-wide association analysis by lasso penalized logistic regression. Bioinformatics 25:714–721

    Article  CAS  Google Scholar 

  19. Thul PJ, Lindskog C (2018) The human protein atlas: a spatial map of the human proteome. Protein Sci 27:233–244

    Article  CAS  Google Scholar 

  20. Lan Y, Xiao X, He Z, Luo Y, Wu C, Li L, Song X (2018) Long noncoding RNA OCC-1 suppresses cell growth through destabilizing HuR protein in colorectal cancer. Nucleic Acids Res 46:5809–5821

    Article  CAS  Google Scholar 

  21. Dong W, Dai ZH, Liu FC, Guo XG, Ge CM, Ding J, Liu H, Yang F (2019) The RNA-binding protein RBM3 promotes cell proliferation in hepatocellular carcinoma by regulating circular RNA SCD-circRNA 2 production. EBioMedicine 45:155–167

    Article  Google Scholar 

  22. Soni S, Anand P, Padwad YS (2019) MAPKAPK2: the master regulator of RNA-binding proteins modulates transcript stability and tumor progression. J Exp Clin Cancer Res 38:121

    Article  Google Scholar 

  23. Schultz CW, Preet R, Dhir T, Dixon DA, Brody JR (2020) Understanding and targeting the disease-related RNA binding protein human antigen R (HuR). Wiley Interdiscip Rev RNA 11:e1581

    Article  CAS  Google Scholar 

  24. Frisone P, Pradella D, Di Matteo A, Belloni E, Ghigna C, Paronetto MP (2015) SAM68: signal transduction and RNA metabolism in human cancer. Biomed Res Int 2015:528954

    Article  Google Scholar 

  25. Perron G, Jandaghi P, Solanki S, Safisamghabadi M, Storoz C, Karimzadeh M, Papadakis AI, Arseneault M, Scelo G, Banks RE et al (2018) A general framework for interrogation of mRNA stability programs identifies RNA-binding proteins that govern cancer transcriptomes. Cell Rep 23:1639–1650

    Article  CAS  Google Scholar 

  26. Wurth L (2012) Versatility of RNA-binding proteins in cancer. Comp Funct Genomics 2012:178525

    Article  Google Scholar 

  27. Lukong KE, Chang KW, Khandjian EW, Richard S (2008) RNA-binding proteins in human genetic disease. Trends Genet 24:416–425

    Article  CAS  Google Scholar 

  28. Zhang H, Brown RD, Stenmark KR, Hu CJ (2020) RNA-binding proteins in pulmonary hypertension. Int J Mol Sci 21:3757

    Article  CAS  Google Scholar 

  29. Zhu S, Rooney S, Michlewski G (2020) RNA-targeted therapies and high-throughput screening methods. Int J Mol Sci 21:2996

    Article  CAS  Google Scholar 

  30. Wong KK (2020) DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications. Cell Oncol (Dordr) 43:779–792

    Article  CAS  Google Scholar 

  31. Kah KW (2020) DNMT1: a key drug target in triple-negative breast cancer. Semin Cancer Biol 72:198–213

    Google Scholar 

  32. Wu L, Gong Y, Yan T, Zhang H (2020) LINP1 promotes the progression of cervical cancer by scaffolding EZH2, LSD1 and DNMT1 to inhibit the expression of KLF2 and PRSS8. Biochem Cell Biol 98:591–599

    Article  CAS  Google Scholar 

  33. Guo T, Zambo KDA, Zamuner FT, Ou T, Hopkins C, Kelley DZ, Wulf HA, Winkler E, Erbe R, Danilova L et al (2020) Chromatin structure regulates cancer-specific alternative splicing events in primary HPV-related oropharyngeal squamous cell carcinoma. Epigenetics 15:1–13

    Article  Google Scholar 

  34. Li J, Feng D, Gao C, Zhang Y, Xu J, Wu M, Zhan X (2019) Isoforms S and L of MRPL33 from alternative splicing have isoformspecific roles in the chemoresponse to epirubicin in gastric cancer cells via the PI3K/AKT signaling pathway. Int J Oncol 54:1591–1600

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Liu L, Luo C, Luo Y, Chen L, Liu Y, Wang Y, Han J, Zhang Y, Wei N, Xie Z et al (2018) MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression. Oncogene 37:86–94

    Article  CAS  Google Scholar 

  36. Hua WF, Zhong Q, Xia TL, Chen Q, Zhang MY, Zhou AJ, Tu ZW, Qu C, Li MZ, Xia YF et al (2016) RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma. Cell Death Dis 7:e2352

    Article  CAS  Google Scholar 

  37. Yang SW, Li L, Connelly JP, Porter SN, Kodali K, Gan H, Park JM, Tacer KF, Tillman H, Peng J et al (2020) A cancer-specific ubiquitin ligase drives mRNA alternative polyadenylation by ubiquitinating the mRNA 3’ end processing complex. Mol Cell 77(1206–1221):e1207

    Google Scholar 

  38. Lu M, Ge Q, Wang G, Luo Y, Wang X, Jiang W, Liu X, Wu CL, Xiao Y, Wang X (2018) CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1alpha. Cell Death Dis 9:1046

    Article  Google Scholar 

  39. Sun D, Wang Y, Wang H, Xin Y (2020) The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2. Cancer Cell Int 20:204

    Article  CAS  Google Scholar 

Download references

Funding

The works were supported by Guizhou Science and Technology Department (Identification of Slug-regulated miRNA in oral squamous cell carcinoma and its mechanism of tumor metastasis inhibition, NO: Qiankehe LH [2014] No. 7012).

Author information

Authors and Affiliations

  1. Department of Oral and Maxillofacial Surgery, Guizhou Provincial People’s Hospital, Guiyang, 550002, Guizhou, China

    Xiaofeng Duan, Xianlin Cheng, Xinhai Yin, Zhao Ke & Jukun Song

Authors
  1. Xiaofeng Duan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xianlin Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xinhai Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhao Ke
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jukun Song
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JKS, XFD, XLC wrote the main manuscript text. JKS, KZ, XLC prepared Figs. 1–9. JKS, XFD contributed to data analysis. All authors reviewed the manuscript.

Corresponding author

Correspondence to Jukun Song.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 44 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Duan, X., Cheng, X., Yin, X. et al. Systematic analysis of the function and prognostic value of RNA binding protein in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 279, 1535–1547 (2022). https://doi.org/10.1007/s00405-021-06929-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-021-06929-9

Keywords

Search

Navigation